Lucy Ghali

Dr Lucy Ghali is an academic researcher affiliated with Middlesex University's School of Natural Sciences. Her work spans molecular biology, cancer research, and biomedical engineering, focusing on targeted drug delivery mechanisms, HPV-related pathologies, and nanoparticle applications in oncology. She has contributed to studies on cervical cancer, breast cancer, and dermatological malignancies through in vitro and clinical research.

Her publications highlight a strong emphasis on pharmacological interventions in oncology, particularly the use of liposomes and gold nanoparticles for arsenic trioxide delivery. She has collaborated extensively with colleagues in pharmacology, dermatology, and biomedical engineering, contributing to advancements in understanding tumor progression and chemotherapy optimization.

Scientific awards are not explicitly mentioned in the provided data. Lucy Ghali's research has been published in journals like BMC Oral Health, IEEE Transactions on Biomedical Engineering, and Nanoscale Advances, alongside presenting at international conferences such as the NCRI Cancer Conference and ICONAN. Her work often intersects with the study of human papillomavirus (HPV) and its role in cancer development.